Global Neurology Software Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Neurology Software plan packages, this contains individuals for individuals wellbeing records, session scheduling, billing and endurance training.
Neurology Software provides the sufferers overall health-related information to assist in wellbeing care decisions. The specialist primarily based plan provides forms similar for his or her paper counterparts however provides easy navigation, a typical paragraph and click solution, discernment and also a standardized interface that allows everyone in workout to be more practical and provide far better wellness health-related treatment towards the patient.
According to APO Research, The global Neurology Software market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Neurology Software is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Neurology Software is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Neurology Software is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Neurology Software is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Neurology Software include Epic, Athenahealth, Nextgen, healthfusion, Allscripts, Greenway Health, Practice Fusion, Brainlab and Kareo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Neurology Software, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Neurology Software, also provides the value of main regions and countries. Of the upcoming market potential for Neurology Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Neurology Software revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Neurology Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Neurology Software company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Neurology Software segment by Company
1. To analyze and research the global Neurology Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Neurology Software key companies, revenue, market share, and recent developments.
3. To split the Neurology Software breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Neurology Software market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Neurology Software significant trends, drivers, influence factors in global and regions.
6. To analyze Neurology Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurology Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurology Software industry.
Chapter 3: Detailed analysis of Neurology Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Neurology Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Neurology Software in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Neurology Software plan packages, this contains individuals for individuals wellbeing records, session scheduling, billing and endurance training.
Neurology Software provides the sufferers overall health-related information to assist in wellbeing care decisions. The specialist primarily based plan provides forms similar for his or her paper counterparts however provides easy navigation, a typical paragraph and click solution, discernment and also a standardized interface that allows everyone in workout to be more practical and provide far better wellness health-related treatment towards the patient.
According to APO Research, The global Neurology Software market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Neurology Software is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Neurology Software is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Neurology Software is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Neurology Software is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Neurology Software include Epic, Athenahealth, Nextgen, healthfusion, Allscripts, Greenway Health, Practice Fusion, Brainlab and Kareo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Neurology Software, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Neurology Software, also provides the value of main regions and countries. Of the upcoming market potential for Neurology Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Neurology Software revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Neurology Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Neurology Software company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Neurology Software segment by Company
- Epic
- Athenahealth
- Nextgen
- healthfusion
- Allscripts
- Greenway Health
- Practice Fusion
- Brainlab
- Kareo
- Bizmatics
- Advanced Data Systems
- NueMD
- Advanced Neurology EMR Software
- Others
- Hospitals
- College & Research Institutes
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Neurology Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Neurology Software key companies, revenue, market share, and recent developments.
3. To split the Neurology Software breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Neurology Software market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Neurology Software significant trends, drivers, influence factors in global and regions.
6. To analyze Neurology Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurology Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurology Software industry.
Chapter 3: Detailed analysis of Neurology Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Neurology Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Neurology Software in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Neurology Software Market Size, 2019 VS 2023 VS 2030
1.3 Global Neurology Software Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 NEUROLOGY SOFTWARE MARKET DYNAMICS
2.1 Neurology Software Industry Trends
2.2 Neurology Software Industry Drivers
2.3 Neurology Software Industry Opportunities and Challenges
2.4 Neurology Software Industry Restraints
3 NEUROLOGY SOFTWARE MARKET BY COMPANY
3.1 Global Neurology Software Company Revenue Ranking in 2023
3.2 Global Neurology Software Revenue by Company (2019-2024)
3.3 Global Neurology Software Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Neurology Software Company Manufacturing Base & Headquarters
3.5 Global Neurology Software Company, Product Type & Application
3.6 Global Neurology Software Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Neurology Software Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Neurology Software Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 NEUROLOGY SOFTWARE MARKET BY TYPE
4.1 Neurology Software Type Introduction
4.1.1 Advanced Neurology EMR Software
4.1.2 Others
4.2 Global Neurology Software Sales Value by Type
4.2.1 Global Neurology Software Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Neurology Software Sales Value by Type (2019-2030)
4.2.3 Global Neurology Software Sales Value Share by Type (2019-2030)
5 NEUROLOGY SOFTWARE MARKET BY APPLICATION
5.1 Neurology Software Application Introduction
5.1.1 Hospitals
5.1.2 College & Research Institutes
5.1.3 Others
5.2 Global Neurology Software Sales Value by Application
5.2.1 Global Neurology Software Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Neurology Software Sales Value by Application (2019-2030)
5.2.3 Global Neurology Software Sales Value Share by Application (2019-2030)
6 NEUROLOGY SOFTWARE MARKET BY REGION
6.1 Global Neurology Software Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Neurology Software Sales Value by Region (2019-2030)
6.2.1 Global Neurology Software Sales Value by Region: 2019-2024
6.2.2 Global Neurology Software Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Neurology Software Sales Value (2019-2030)
6.3.2 North America Neurology Software Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Neurology Software Sales Value (2019-2030)
6.4.2 Europe Neurology Software Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Neurology Software Sales Value (2019-2030)
6.5.2 Asia-Pacific Neurology Software Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Neurology Software Sales Value (2019-2030)
6.6.2 Latin America Neurology Software Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Neurology Software Sales Value (2019-2030)
6.7.2 Middle East & Africa Neurology Software Sales Value Share by Country, 2023 VS 2030
7 NEUROLOGY SOFTWARE MARKET BY COUNTRY
7.1 Global Neurology Software Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Neurology Software Sales Value by Country (2019-2030)
7.2.1 Global Neurology Software Sales Value by Country (2019-2024)
7.2.2 Global Neurology Software Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.3.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.4.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.5.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.6.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.7.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.8.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.9.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.10.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.11.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.12.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.13.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.14.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.15.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.16.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.17.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.18.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.19.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.20.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.21.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Epic
8.1.1 Epic Comapny Information
8.1.2 Epic Business Overview
8.1.3 Epic Neurology Software Revenue and Gross Margin (2019-2024)
8.1.4 Epic Neurology Software Product Portfolio
8.1.5 Epic Recent Developments
8.2 Athenahealth
8.2.1 Athenahealth Comapny Information
8.2.2 Athenahealth Business Overview
8.2.3 Athenahealth Neurology Software Revenue and Gross Margin (2019-2024)
8.2.4 Athenahealth Neurology Software Product Portfolio
8.2.5 Athenahealth Recent Developments
8.3 Nextgen
8.3.1 Nextgen Comapny Information
8.3.2 Nextgen Business Overview
8.3.3 Nextgen Neurology Software Revenue and Gross Margin (2019-2024)
8.3.4 Nextgen Neurology Software Product Portfolio
8.3.5 Nextgen Recent Developments
8.4 healthfusion
8.4.1 healthfusion Comapny Information
8.4.2 healthfusion Business Overview
8.4.3 healthfusion Neurology Software Revenue and Gross Margin (2019-2024)
8.4.4 healthfusion Neurology Software Product Portfolio
8.4.5 healthfusion Recent Developments
8.5 Allscripts
8.5.1 Allscripts Comapny Information
8.5.2 Allscripts Business Overview
8.5.3 Allscripts Neurology Software Revenue and Gross Margin (2019-2024)
8.5.4 Allscripts Neurology Software Product Portfolio
8.5.5 Allscripts Recent Developments
8.6 Greenway Health
8.6.1 Greenway Health Comapny Information
8.6.2 Greenway Health Business Overview
8.6.3 Greenway Health Neurology Software Revenue and Gross Margin (2019-2024)
8.6.4 Greenway Health Neurology Software Product Portfolio
8.6.5 Greenway Health Recent Developments
8.7 Practice Fusion
8.7.1 Practice Fusion Comapny Information
8.7.2 Practice Fusion Business Overview
8.7.3 Practice Fusion Neurology Software Revenue and Gross Margin (2019-2024)
8.7.4 Practice Fusion Neurology Software Product Portfolio
8.7.5 Practice Fusion Recent Developments
8.8 Brainlab
8.8.1 Brainlab Comapny Information
8.8.2 Brainlab Business Overview
8.8.3 Brainlab Neurology Software Revenue and Gross Margin (2019-2024)
8.8.4 Brainlab Neurology Software Product Portfolio
8.8.5 Brainlab Recent Developments
8.9 Kareo
8.9.1 Kareo Comapny Information
8.9.2 Kareo Business Overview
8.9.3 Kareo Neurology Software Revenue and Gross Margin (2019-2024)
8.9.4 Kareo Neurology Software Product Portfolio
8.9.5 Kareo Recent Developments
8.10 Bizmatics
8.10.1 Bizmatics Comapny Information
8.10.2 Bizmatics Business Overview
8.10.3 Bizmatics Neurology Software Revenue and Gross Margin (2019-2024)
8.10.4 Bizmatics Neurology Software Product Portfolio
8.10.5 Bizmatics Recent Developments
8.11 Advanced Data Systems
8.11.1 Advanced Data Systems Comapny Information
8.11.2 Advanced Data Systems Business Overview
8.11.3 Advanced Data Systems Neurology Software Revenue and Gross Margin (2019-2024)
8.11.4 Advanced Data Systems Neurology Software Product Portfolio
8.11.5 Advanced Data Systems Recent Developments
8.12 NueMD
8.12.1 NueMD Comapny Information
8.12.2 NueMD Business Overview
8.12.3 NueMD Neurology Software Revenue and Gross Margin (2019-2024)
8.12.4 NueMD Neurology Software Product Portfolio
8.12.5 NueMD Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
1.1 Product Definition
1.2 Global Neurology Software Market Size, 2019 VS 2023 VS 2030
1.3 Global Neurology Software Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 NEUROLOGY SOFTWARE MARKET DYNAMICS
2.1 Neurology Software Industry Trends
2.2 Neurology Software Industry Drivers
2.3 Neurology Software Industry Opportunities and Challenges
2.4 Neurology Software Industry Restraints
3 NEUROLOGY SOFTWARE MARKET BY COMPANY
3.1 Global Neurology Software Company Revenue Ranking in 2023
3.2 Global Neurology Software Revenue by Company (2019-2024)
3.3 Global Neurology Software Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Neurology Software Company Manufacturing Base & Headquarters
3.5 Global Neurology Software Company, Product Type & Application
3.6 Global Neurology Software Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Neurology Software Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Neurology Software Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 NEUROLOGY SOFTWARE MARKET BY TYPE
4.1 Neurology Software Type Introduction
4.1.1 Advanced Neurology EMR Software
4.1.2 Others
4.2 Global Neurology Software Sales Value by Type
4.2.1 Global Neurology Software Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Neurology Software Sales Value by Type (2019-2030)
4.2.3 Global Neurology Software Sales Value Share by Type (2019-2030)
5 NEUROLOGY SOFTWARE MARKET BY APPLICATION
5.1 Neurology Software Application Introduction
5.1.1 Hospitals
5.1.2 College & Research Institutes
5.1.3 Others
5.2 Global Neurology Software Sales Value by Application
5.2.1 Global Neurology Software Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Neurology Software Sales Value by Application (2019-2030)
5.2.3 Global Neurology Software Sales Value Share by Application (2019-2030)
6 NEUROLOGY SOFTWARE MARKET BY REGION
6.1 Global Neurology Software Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Neurology Software Sales Value by Region (2019-2030)
6.2.1 Global Neurology Software Sales Value by Region: 2019-2024
6.2.2 Global Neurology Software Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Neurology Software Sales Value (2019-2030)
6.3.2 North America Neurology Software Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Neurology Software Sales Value (2019-2030)
6.4.2 Europe Neurology Software Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Neurology Software Sales Value (2019-2030)
6.5.2 Asia-Pacific Neurology Software Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Neurology Software Sales Value (2019-2030)
6.6.2 Latin America Neurology Software Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Neurology Software Sales Value (2019-2030)
6.7.2 Middle East & Africa Neurology Software Sales Value Share by Country, 2023 VS 2030
7 NEUROLOGY SOFTWARE MARKET BY COUNTRY
7.1 Global Neurology Software Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Neurology Software Sales Value by Country (2019-2030)
7.2.1 Global Neurology Software Sales Value by Country (2019-2024)
7.2.2 Global Neurology Software Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.3.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.4.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.5.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.6.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.7.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.8.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.9.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.10.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.11.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.12.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.13.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.14.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.15.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.16.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.17.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.18.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.19.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.20.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Neurology Software Sales Value Growth Rate (2019-2030)
7.21.2 Global Neurology Software Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Neurology Software Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Epic
8.1.1 Epic Comapny Information
8.1.2 Epic Business Overview
8.1.3 Epic Neurology Software Revenue and Gross Margin (2019-2024)
8.1.4 Epic Neurology Software Product Portfolio
8.1.5 Epic Recent Developments
8.2 Athenahealth
8.2.1 Athenahealth Comapny Information
8.2.2 Athenahealth Business Overview
8.2.3 Athenahealth Neurology Software Revenue and Gross Margin (2019-2024)
8.2.4 Athenahealth Neurology Software Product Portfolio
8.2.5 Athenahealth Recent Developments
8.3 Nextgen
8.3.1 Nextgen Comapny Information
8.3.2 Nextgen Business Overview
8.3.3 Nextgen Neurology Software Revenue and Gross Margin (2019-2024)
8.3.4 Nextgen Neurology Software Product Portfolio
8.3.5 Nextgen Recent Developments
8.4 healthfusion
8.4.1 healthfusion Comapny Information
8.4.2 healthfusion Business Overview
8.4.3 healthfusion Neurology Software Revenue and Gross Margin (2019-2024)
8.4.4 healthfusion Neurology Software Product Portfolio
8.4.5 healthfusion Recent Developments
8.5 Allscripts
8.5.1 Allscripts Comapny Information
8.5.2 Allscripts Business Overview
8.5.3 Allscripts Neurology Software Revenue and Gross Margin (2019-2024)
8.5.4 Allscripts Neurology Software Product Portfolio
8.5.5 Allscripts Recent Developments
8.6 Greenway Health
8.6.1 Greenway Health Comapny Information
8.6.2 Greenway Health Business Overview
8.6.3 Greenway Health Neurology Software Revenue and Gross Margin (2019-2024)
8.6.4 Greenway Health Neurology Software Product Portfolio
8.6.5 Greenway Health Recent Developments
8.7 Practice Fusion
8.7.1 Practice Fusion Comapny Information
8.7.2 Practice Fusion Business Overview
8.7.3 Practice Fusion Neurology Software Revenue and Gross Margin (2019-2024)
8.7.4 Practice Fusion Neurology Software Product Portfolio
8.7.5 Practice Fusion Recent Developments
8.8 Brainlab
8.8.1 Brainlab Comapny Information
8.8.2 Brainlab Business Overview
8.8.3 Brainlab Neurology Software Revenue and Gross Margin (2019-2024)
8.8.4 Brainlab Neurology Software Product Portfolio
8.8.5 Brainlab Recent Developments
8.9 Kareo
8.9.1 Kareo Comapny Information
8.9.2 Kareo Business Overview
8.9.3 Kareo Neurology Software Revenue and Gross Margin (2019-2024)
8.9.4 Kareo Neurology Software Product Portfolio
8.9.5 Kareo Recent Developments
8.10 Bizmatics
8.10.1 Bizmatics Comapny Information
8.10.2 Bizmatics Business Overview
8.10.3 Bizmatics Neurology Software Revenue and Gross Margin (2019-2024)
8.10.4 Bizmatics Neurology Software Product Portfolio
8.10.5 Bizmatics Recent Developments
8.11 Advanced Data Systems
8.11.1 Advanced Data Systems Comapny Information
8.11.2 Advanced Data Systems Business Overview
8.11.3 Advanced Data Systems Neurology Software Revenue and Gross Margin (2019-2024)
8.11.4 Advanced Data Systems Neurology Software Product Portfolio
8.11.5 Advanced Data Systems Recent Developments
8.12 NueMD
8.12.1 NueMD Comapny Information
8.12.2 NueMD Business Overview
8.12.3 NueMD Neurology Software Revenue and Gross Margin (2019-2024)
8.12.4 NueMD Neurology Software Product Portfolio
8.12.5 NueMD Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
LIST OF TABLES
Table 1. Neurology Software Industry Trends
Table 2. Neurology Software Industry Drivers
Table 3. Neurology Software Industry Opportunities and Challenges
Table 4. Neurology Software Industry Restraints
Table 5. Global Neurology Software Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Neurology Software Revenue Share by Company (2019-2024)
Table 7. Global Neurology Software Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Neurology Software Key Company Manufacturing Base & Headquarters
Table 9. Global Neurology Software Company, Product Type & Application
Table 10. Global Neurology Software Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Neurology Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Advanced Neurology EMR Software
Table 15. Major Companies of Others
Table 16. Global Neurology Software Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Neurology Software Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Neurology Software Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Neurology Software Sales Value Share by Type (2019-2024)
Table 20. Global Neurology Software Sales Value Share by Type (2025-2030)
Table 21. Major Companies of Hospitals
Table 22. Major Companies of College & Research Institutes
Table 23. Major Companies of Others
Table 24. Global Neurology Software Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Neurology Software Sales Value by Application (2019-2024) & (US$ Million)
Table 26. Global Neurology Software Sales Value by Application (2025-2030) & (US$ Million)
Table 27. Global Neurology Software Sales Value Share by Application (2019-2024)
Table 28. Global Neurology Software Sales Value Share by Application (2025-2030)
Table 29. Global Neurology Software Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Neurology Software Sales Value by Region (2019-2024) & (US$ Million)
Table 31. Global Neurology Software Sales Value Share by Region (2019-2024)
Table 32. Global Neurology Software Sales Value by Region (2025-2030) & (US$ Million)
Table 33. Global Neurology Software Sales Value Share by Region (2025-2030)
Table 34. Global Neurology Software Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 35. Global Neurology Software Sales Value by Country (2019-2024) & (US$ Million)
Table 36. Global Neurology Software Sales Value Market Share by Country (2019-2024)
Table 37. Global Neurology Software Sales Value by Country (2025-2030) & (US$ Million)
Table 38. Global Neurology Software Sales Value Market Share by Country (2025-2030)
Table 39. Epic Company Information
Table 40. Epic Business Overview
Table 41. Epic Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 42. Epic Neurology Software Product Portfolio
Table 43. Epic Recent Development
Table 44. Athenahealth Company Information
Table 45. Athenahealth Business Overview
Table 46. Athenahealth Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 47. Athenahealth Neurology Software Product Portfolio
Table 48. Athenahealth Recent Development
Table 49. Nextgen Company Information
Table 50. Nextgen Business Overview
Table 51. Nextgen Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 52. Nextgen Neurology Software Product Portfolio
Table 53. Nextgen Recent Development
Table 54. healthfusion Company Information
Table 55. healthfusion Business Overview
Table 56. healthfusion Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 57. healthfusion Neurology Software Product Portfolio
Table 58. healthfusion Recent Development
Table 59. Allscripts Company Information
Table 60. Allscripts Business Overview
Table 61. Allscripts Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 62. Allscripts Neurology Software Product Portfolio
Table 63. Allscripts Recent Development
Table 64. Greenway Health Company Information
Table 65. Greenway Health Business Overview
Table 66. Greenway Health Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 67. Greenway Health Neurology Software Product Portfolio
Table 68. Greenway Health Recent Development
Table 69. Practice Fusion Company Information
Table 70. Practice Fusion Business Overview
Table 71. Practice Fusion Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 72. Practice Fusion Neurology Software Product Portfolio
Table 73. Practice Fusion Recent Development
Table 74. Brainlab Company Information
Table 75. Brainlab Business Overview
Table 76. Brainlab Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 77. Brainlab Neurology Software Product Portfolio
Table 78. Brainlab Recent Development
Table 79. Kareo Company Information
Table 80. Kareo Business Overview
Table 81. Kareo Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 82. Kareo Neurology Software Product Portfolio
Table 83. Kareo Recent Development
Table 84. Bizmatics Company Information
Table 85. Bizmatics Business Overview
Table 86. Bizmatics Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 87. Bizmatics Neurology Software Product Portfolio
Table 88. Bizmatics Recent Development
Table 89. Advanced Data Systems Company Information
Table 90. Advanced Data Systems Business Overview
Table 91. Advanced Data Systems Neurology Software Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Advanced Data Systems Neurology Software Product Portfolio
Table 93. Advanced Data Systems Recent Development
Table 94. NueMD Company Information
Table 95. NueMD Business Overview
Table 96. NueMD Neurology Software Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. NueMD Neurology Software Product Portfolio
Table 98. NueMD Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Authors List of This Report
Table 101. Secondary Sources
Table 102. Primary Sources
Table 1. Neurology Software Industry Trends
Table 2. Neurology Software Industry Drivers
Table 3. Neurology Software Industry Opportunities and Challenges
Table 4. Neurology Software Industry Restraints
Table 5. Global Neurology Software Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Neurology Software Revenue Share by Company (2019-2024)
Table 7. Global Neurology Software Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Neurology Software Key Company Manufacturing Base & Headquarters
Table 9. Global Neurology Software Company, Product Type & Application
Table 10. Global Neurology Software Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Neurology Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Advanced Neurology EMR Software
Table 15. Major Companies of Others
Table 16. Global Neurology Software Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Neurology Software Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Neurology Software Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Neurology Software Sales Value Share by Type (2019-2024)
Table 20. Global Neurology Software Sales Value Share by Type (2025-2030)
Table 21. Major Companies of Hospitals
Table 22. Major Companies of College & Research Institutes
Table 23. Major Companies of Others
Table 24. Global Neurology Software Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Neurology Software Sales Value by Application (2019-2024) & (US$ Million)
Table 26. Global Neurology Software Sales Value by Application (2025-2030) & (US$ Million)
Table 27. Global Neurology Software Sales Value Share by Application (2019-2024)
Table 28. Global Neurology Software Sales Value Share by Application (2025-2030)
Table 29. Global Neurology Software Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Neurology Software Sales Value by Region (2019-2024) & (US$ Million)
Table 31. Global Neurology Software Sales Value Share by Region (2019-2024)
Table 32. Global Neurology Software Sales Value by Region (2025-2030) & (US$ Million)
Table 33. Global Neurology Software Sales Value Share by Region (2025-2030)
Table 34. Global Neurology Software Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 35. Global Neurology Software Sales Value by Country (2019-2024) & (US$ Million)
Table 36. Global Neurology Software Sales Value Market Share by Country (2019-2024)
Table 37. Global Neurology Software Sales Value by Country (2025-2030) & (US$ Million)
Table 38. Global Neurology Software Sales Value Market Share by Country (2025-2030)
Table 39. Epic Company Information
Table 40. Epic Business Overview
Table 41. Epic Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 42. Epic Neurology Software Product Portfolio
Table 43. Epic Recent Development
Table 44. Athenahealth Company Information
Table 45. Athenahealth Business Overview
Table 46. Athenahealth Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 47. Athenahealth Neurology Software Product Portfolio
Table 48. Athenahealth Recent Development
Table 49. Nextgen Company Information
Table 50. Nextgen Business Overview
Table 51. Nextgen Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 52. Nextgen Neurology Software Product Portfolio
Table 53. Nextgen Recent Development
Table 54. healthfusion Company Information
Table 55. healthfusion Business Overview
Table 56. healthfusion Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 57. healthfusion Neurology Software Product Portfolio
Table 58. healthfusion Recent Development
Table 59. Allscripts Company Information
Table 60. Allscripts Business Overview
Table 61. Allscripts Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 62. Allscripts Neurology Software Product Portfolio
Table 63. Allscripts Recent Development
Table 64. Greenway Health Company Information
Table 65. Greenway Health Business Overview
Table 66. Greenway Health Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 67. Greenway Health Neurology Software Product Portfolio
Table 68. Greenway Health Recent Development
Table 69. Practice Fusion Company Information
Table 70. Practice Fusion Business Overview
Table 71. Practice Fusion Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 72. Practice Fusion Neurology Software Product Portfolio
Table 73. Practice Fusion Recent Development
Table 74. Brainlab Company Information
Table 75. Brainlab Business Overview
Table 76. Brainlab Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 77. Brainlab Neurology Software Product Portfolio
Table 78. Brainlab Recent Development
Table 79. Kareo Company Information
Table 80. Kareo Business Overview
Table 81. Kareo Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 82. Kareo Neurology Software Product Portfolio
Table 83. Kareo Recent Development
Table 84. Bizmatics Company Information
Table 85. Bizmatics Business Overview
Table 86. Bizmatics Neurology Software Revenue (US$ Million) and Gross Margin (2019-2024)
Table 87. Bizmatics Neurology Software Product Portfolio
Table 88. Bizmatics Recent Development
Table 89. Advanced Data Systems Company Information
Table 90. Advanced Data Systems Business Overview
Table 91. Advanced Data Systems Neurology Software Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Advanced Data Systems Neurology Software Product Portfolio
Table 93. Advanced Data Systems Recent Development
Table 94. NueMD Company Information
Table 95. NueMD Business Overview
Table 96. NueMD Neurology Software Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. NueMD Neurology Software Product Portfolio
Table 98. NueMD Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Authors List of This Report
Table 101. Secondary Sources
Table 102. Primary Sources
LIST OF FIGURES
Figure 1. Neurology Software Product Picture
Figure 2. Global Neurology Software Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Neurology Software Market Size (2019-2030) & (US$ Million)
Figure 4. Global Neurology Software Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Advanced Neurology EMR Software Picture
Figure 8. Others Picture
Figure 9. Global Neurology Software Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 10. Global Neurology Software Sales Value Share 2019 VS 2023 VS 2030
Figure 11. Global Neurology Software Sales Value Share by Type (2019-2030)
Figure 12. Hospitals Picture
Figure 13. College & Research Institutes Picture
Figure 14. Others Picture
Figure 15. Global Neurology Software Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Neurology Software Sales Value Share 2019 VS 2023 VS 2030
Figure 17. Global Neurology Software Sales Value Share by Application (2019-2030)
Figure 18. Global Neurology Software Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 19. Global Neurology Software Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 20. North America Neurology Software Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Neurology Software Sales Value Share by Country (%), 2023 VS 2030
Figure 22. Europe Neurology Software Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Neurology Software Sales Value Share by Country (%), 2023 VS 2030
Figure 24. Asia-Pacific Neurology Software Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia-Pacific Neurology Software Sales Value Share by Country (%), 2023 VS 2030
Figure 26. Latin America Neurology Software Sales Value (2019-2030) & (US$ Million)
Figure 27. Latin America Neurology Software Sales Value Share by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Neurology Software Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Neurology Software Sales Value Share by Country (%), 2023 VS 2030
Figure 30. USA Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 31. USA Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 32. USA Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 33. Canada Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 34. Canada Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 35. Canada Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 36. Germany Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 37. Germany Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 38. Germany Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 39. France Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 40. France Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 41. France Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 42. U.K. Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. U.K. Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. U.K. Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. Italy Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. Italy Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. Italy Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. Netherlands Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. Netherlands Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. Netherlands Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. Nordic Countries Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. Nordic Countries Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 53. Nordic Countries Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 54. China Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 55. China Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 56. China Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 57. Japan Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 58. Japan Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 59. Japan Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 60. South Korea Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. South Korea Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 62. South Korea Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 63. Southeast Asia Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 64. Southeast Asia Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 65. Southeast Asia Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 66. India Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 67. India Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 68. India Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 69. Australia Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 70. Australia Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 71. Australia Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 72. Mexico Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 73. Mexico Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 74. Mexico Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 75. Brazil Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. Brazil Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 77. Brazil Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 78. Turkey Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. Turkey Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 80. Turkey Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 81. Saudi Arabia Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 82. Saudi Arabia Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 83. Saudi Arabia Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 84. UAE Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 85. UAE Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 86. UAE Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 87. Years Considered
Figure 88. Research Process
Figure 89. Key Executives Interviewed
Figure 1. Neurology Software Product Picture
Figure 2. Global Neurology Software Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Neurology Software Market Size (2019-2030) & (US$ Million)
Figure 4. Global Neurology Software Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Advanced Neurology EMR Software Picture
Figure 8. Others Picture
Figure 9. Global Neurology Software Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 10. Global Neurology Software Sales Value Share 2019 VS 2023 VS 2030
Figure 11. Global Neurology Software Sales Value Share by Type (2019-2030)
Figure 12. Hospitals Picture
Figure 13. College & Research Institutes Picture
Figure 14. Others Picture
Figure 15. Global Neurology Software Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Neurology Software Sales Value Share 2019 VS 2023 VS 2030
Figure 17. Global Neurology Software Sales Value Share by Application (2019-2030)
Figure 18. Global Neurology Software Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 19. Global Neurology Software Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 20. North America Neurology Software Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Neurology Software Sales Value Share by Country (%), 2023 VS 2030
Figure 22. Europe Neurology Software Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Neurology Software Sales Value Share by Country (%), 2023 VS 2030
Figure 24. Asia-Pacific Neurology Software Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia-Pacific Neurology Software Sales Value Share by Country (%), 2023 VS 2030
Figure 26. Latin America Neurology Software Sales Value (2019-2030) & (US$ Million)
Figure 27. Latin America Neurology Software Sales Value Share by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Neurology Software Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Neurology Software Sales Value Share by Country (%), 2023 VS 2030
Figure 30. USA Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 31. USA Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 32. USA Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 33. Canada Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 34. Canada Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 35. Canada Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 36. Germany Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 37. Germany Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 38. Germany Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 39. France Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 40. France Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 41. France Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 42. U.K. Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. U.K. Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. U.K. Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. Italy Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. Italy Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. Italy Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. Netherlands Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. Netherlands Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. Netherlands Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. Nordic Countries Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. Nordic Countries Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 53. Nordic Countries Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 54. China Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 55. China Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 56. China Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 57. Japan Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 58. Japan Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 59. Japan Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 60. South Korea Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. South Korea Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 62. South Korea Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 63. Southeast Asia Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 64. Southeast Asia Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 65. Southeast Asia Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 66. India Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 67. India Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 68. India Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 69. Australia Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 70. Australia Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 71. Australia Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 72. Mexico Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 73. Mexico Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 74. Mexico Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 75. Brazil Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. Brazil Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 77. Brazil Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 78. Turkey Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. Turkey Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 80. Turkey Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 81. Saudi Arabia Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 82. Saudi Arabia Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 83. Saudi Arabia Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 84. UAE Neurology Software Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 85. UAE Neurology Software Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 86. UAE Neurology Software Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 87. Years Considered
Figure 88. Research Process
Figure 89. Key Executives Interviewed
